Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug

16 5 月, 2025

One Min Read

39 Views

原文: https://www.investors.com/news/technology/biohaven-stock-delay-troriluzole-sca/?src=A00220&yptr=yahoo

Last Update: 16 5 月, 2025

Written By

Other Articles

Previous

UnitedHealth Stock Selloff Deepens on Report of Medicare Fraud Investigation. It Keeps Getting Worse.

Next

Coinbase股价因SEC调查用户数量而下跌

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept